All In MedTech

Device Trial Radar · NCT02482766

Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With RDS

Efficacy of a New Technique -"IN-REC-SUR-E"- in Preterm Neonates With Respiratory Distress Syndrome During Non Invasive Ventilation: a Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Feb 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 206 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

206

Actual

Start

Nov 2015

Primary completion

Sep 2018

Study completion Sep 30, 2018

Sponsor

Lead sponsor
Catholic University of the Sacred HeartAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ospedali Riuniti Ancona; Careggi Hospital; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Centre for Neonatal Research and Education, Crawley, West Australia; Monash University; Azienda Ospedaliera San Gerardo di Monza; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
First posted
Jun 26, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 24 weeks, up to 27 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary hypothesis of this study is reduction in need of mechanical ventilation in the first 72 hours of life (excluding the transient tracheal intubation performed for surfactant administration and the mechanical ventilation for lung recruitment) in spontaneously breathing infants born at 24+0-27+6 weeks' gestation and failing nCPAP during the first 24 hours of life who received an HFOV recruitment maneuver (IN-REC-SUR-E) compared to no recruitment maneuver (IN-SUR-E) just prior to surfactant administration followed by prompt extubation.

Conditions

  • Respiratory Distress Syndrome
  • Hyaline Membrane Disease

Interventions

  • Poractant alfa, 200 mg/kgDrug

    Endotracheal Surfactant administration

  • Ventilator for High-frequency Oscillatory Ventilation (HFOV)Device

    This device will be used to perform an HFOV recruitment maneuver before surfactant administration

  • Nasal Continuous Positive Airway Pressure (nCPAP)Device

    After surfactant administration, the babies will be extubated within 30 minutes and will receive nCPAP (6-8 cm H2O)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Need for mechanical ventilation within the first 3 days of life and therefore we consider IN-REC-SUR-E a success if mechanical ventilation is not required and a failure if the infant needs mechanical ventilation in the first 72 hours.Time frame: First 72 hours of life

Locations

33 sites in 1 country. Site status is shown where the registry gives one.

  • SS Antonio e Biagio e Cesare Arrigo

    Alessandria, Italy

  • Azienda Ospedaliera Universitaria Ferrara

    Ferrara, Italy

  • Careggi

    Florence, Italy

30 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.